Life ScienceCompany
Auregen BioTherapeutics Ownership
Who owns Auregen BioTherapeutics?
Auregen BioTherapeutics is owned by Gurnet Point Capital. It was acquired on December 1, 2016.
Is Auregen BioTherapeutics PE-backed?
Yes. Auregen BioTherapeutics is owned by private equity investor Gurnet Point Capital.
Auregen BioTherapeutics Business Overview
Where is Auregen BioTherapeutics headquartered?
Auregen BioTherapeutics is headquartered in Cambridge, Massachusetts.
What sector is Auregen BioTherapeutics in?
Auregen BioTherapeutics is a life science company.
Life Science M&A Summary in 2016
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.
Join Mergr to view all 295 acquisitions of life science companies in 2016, including 33 acquisitions by private equity firms, and 262 by strategics.